Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Zhenao Pharmaceutical
Dalian, Liaoning, China
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Dalian Zhenao Pharmaceutical is a leading Chinese pharmaceutical company specializing in nucleic acid-based medicine. It is a core subsidiary of the Zhenao Group and is recognized for its industrial-scale production of nucleic acid raw materials and finished drugs, including interferon inducers and liver-supporting therapeutics.
- Therapeutic areas
- ImmunologyCardiovascularInfectious DiseasesGastroenterologyOncology
- Modalities
- RNA therapySmall moleculeBiologicPeptides
- Industry
- Biotech
02
Partnerships
Chinese Academy of SciencesFudan University
Beyond the preview
Go deeper on Dalian Zhenao Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dalian Zhenao Pharmaceutical.